Works matching IS 17562856 AND DT 2010 AND VI 3 AND IP 1
Results: 6
A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing—remitting multiple sclerosis (TIME MS).
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 1, p. 3, doi. 10.1177/1756285609355851
- By:
- Publication type:
- Article
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 1, p. 15, doi. 10.1177/1756285609353354
- By:
- Publication type:
- Article
Review: Discordant findings in color-coded duplex-sonography and magnetic resonance angiography in symptomatic internal carotid artery stenosis: implications for diagnostic work-up and early intervention.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 1, p. 69, doi. 10.1177/1756285609351763
- By:
- Publication type:
- Article
Review: Progress in the management of paraneoplastic neurological disorders.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 1, p. 43, doi. 10.1177/1756285609349521
- By:
- Publication type:
- Article
Review: Treatment of dysautonomia in extrapyramidal disorders.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 1, p. 53, doi. 10.1177/1756285609348902
- By:
- Publication type:
- Article
Review: Diagnosis and treatment of cerebral vasculitis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 1, p. 29, doi. 10.1177/1756285609347123
- By:
- Publication type:
- Article